114 related articles for article (PubMed ID: 2937532)
1. Hormonal therapies for breast cancer: can progestogens stimulate growth?
Braunsberg HA; Coldham NG; Wong W
Cancer Lett; 1986 Feb; 30(2):213-8. PubMed ID: 2937532
[TBL] [Abstract][Full Text] [Related]
2. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
3. Actions of a progestogen on human breast cancer cells: mechanisms of growth stimulation and inhibition.
Braunsberg H; Coldham NG; Leake RE; Cowan SK; Wong W
Eur J Cancer Clin Oncol; 1987 May; 23(5):563-71. PubMed ID: 2958286
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
Mueck AO; Seeger H; Wallwiener D
Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
[TBL] [Abstract][Full Text] [Related]
5. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative effect of leuprorelin acetate, alone or combined with tamoxifen or medroxyprogesterone acetate, on human breast cancer cell lines.
Sica G; Iacopino F; Marini L; Robustelli della Cuna G
Clin Ther; 1992; 14 Suppl A():87-96. PubMed ID: 1535023
[TBL] [Abstract][Full Text] [Related]
7. Progestational agents in advanced breast cancer: an overview.
Haller DG; Glick JH
Semin Oncol; 1986 Dec; 13(4 Suppl 4):2-8. PubMed ID: 3026051
[TBL] [Abstract][Full Text] [Related]
8. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells].
Nomura Y; Tashiro H; Takaeko F
Gan To Kagaku Ryoho; 1985 Apr; 12(4):844-50. PubMed ID: 3157351
[TBL] [Abstract][Full Text] [Related]
9. The role of progestins in the treatment of breast cancer.
Blumenschein GR
Semin Oncol; 1983 Dec; 10(4 Suppl 4):7-10. PubMed ID: 6230722
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells.
Seeger H; Rakov V; Mueck AO
Horm Metab Res; 2005 Aug; 37(8):468-73. PubMed ID: 16138258
[TBL] [Abstract][Full Text] [Related]
11. Hormone and cytotoxic drug responsiveness of cultured human breast cancer cells resistant to specific hormones.
Coldham NG; Patel K; Braunsberg H
Int J Cancer; 1990 Apr; 45(4):712-8. PubMed ID: 2139015
[TBL] [Abstract][Full Text] [Related]
12. Adriamycin action on human breast cancer cells: enhancement by medroxyprogesterone acetate.
Shaikh NA; Owen AM; Ghilchik MW; Braunsberg H
Int J Cancer; 1989 Apr; 43(4):733-6. PubMed ID: 2522913
[TBL] [Abstract][Full Text] [Related]
13. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
Seeger H; Wallwiener D; Mueck AO
Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101
[TBL] [Abstract][Full Text] [Related]
14. The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells.
Neubauer H; Yang Y; Seeger H; Fehm T; Cahill MA; Tong X; Ruan X; Mueck AO
Menopause; 2011 Aug; 18(8):845-50. PubMed ID: 21532513
[TBL] [Abstract][Full Text] [Related]
15. [Influence of endocrine therapy on the proliferation of estrogen (ER) positive cells and ER negative cells of human breast cancer (MCF-7)].
Noguchi M; Tajiri K; Taniya T; Kumaki T; Miyazaki I
Nihon Geka Gakkai Zasshi; 1989 May; 90(5):780-5. PubMed ID: 2529423
[TBL] [Abstract][Full Text] [Related]
16. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
[TBL] [Abstract][Full Text] [Related]
17. Current status of high dose progestin treatment in advanced breast cancer.
Mattsson W
Breast Cancer Res Treat; 1983; 3(2):231-5. PubMed ID: 6225476
[TBL] [Abstract][Full Text] [Related]
18. Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo.
Leveque J; Foucher F; Havouis R; Desury D; Grall JY; Moulinoux JP
Anticancer Res; 2000; 20(1A):97-101. PubMed ID: 10769640
[TBL] [Abstract][Full Text] [Related]
19. On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.
Petru E; Schmähl D
Klin Wochenschr; 1987 Oct; 65(20):959-66. PubMed ID: 2963170
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells.
Xu B; Kitawaki J; Koshiba H; Ishihara H; Kiyomizu M; Teramoto M; Kitaoka Y; Honjo H
Maturitas; 2007 Feb; 56(2):142-52. PubMed ID: 16962266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
